COVID-19: PROPRIETARY MODELS SET TO MONITOR PANDEMIC EVOLUTION

At the end of 2020, a new coronavirus started spreading in China. A few months later, it was already all around the world, changing the life and habits of billions of people.

Highlights:

  • In this report we present stylized facts and regularities of the spread of the virus deriving from 4 proprietary statistical models which focus on: short-term forecast of contagions and deaths, longer term Gaussian model for deaths estimate and, finally, current estimate for total real cases.
  • We advocate basing cases estimates on deaths as a stable measure, less affected by testing issues than cases.
  • The evolution in the pattern of contagion rates in Western countries is typical and quite predictable: an initial outbreak with very high contagion rates followed by linear moderation as habits change and containment measures step in.
  • Some Eastern countries which succeeded in containing the virus have patterns that either skip the initial acute phase (Japan) or contain it very rapidly (Korea), leading to dramatically lower total cases and lesser strain on the Health system.
  • Gaussian models of the epidemic’s evolution predict the peaks well (and hence the maximum strain on intensive care) but the dying out phase is slower than the bell-shape curves would predict.
  • The actual number of infected people is a multiple of the official figure, and can be roughly estimated at around 100 times the official deaths.
  • The typical trajectory of an eventual new outbreak (second wave) would probably skip the initial acute phase due to the improved degree of cultural and material preparation, looking more like the Japanese case than what was experienced by Western countries.

Download the full publication below

COVID-19: PROPRIETARY MODELS SET TO MONITOR PANDEMIC EVOLUTION

RELATED INSIGHTS

COVID-19 FACTS & FIGURES
Pfizer and BioNTech candidate Covid-19 vaccine showed to be 95% effective in early analysis, an even better result compared to data released last week. Moderna candidate Covid-19 vaccine showed to be 94.5% effective in early trials involving 30,000 people. Switzerland announced ICU beds reached full capacity and no extra units are available. Oxford and AstraZeneca Covid-19 vaccine test results are expected by late December.
THE FED REMAINS SILENT ON CHANGES TO QE AND CALLS FOR FURTHER FISCAL STIMULUS
As widely expected, the November meeting was rather uneventful: chair Powell seized the opportunity to reiterate the strong forward guidance on rates illustrated in September and to reassure on the capability of unorthodox measures to cushion a possible downturn of the economy.
CHINA’S NEW “DUAL CIRCULATION STRATEGY”
At the end of October, China approved its “Dual Circulation Strategy” which is the new five-year economic plan (2021 – 2025). The concept has been under discussion for quite some time and President Xi highlighted it already in May. In a nutshell, the concept promotes domestic demand as the central growth engine. It foresees more independent and resilient supply chains while at the same time it intends to further opening-up the corporate sector and financial markets.